David Brzostowicki

News

New Five-Type Index Provides Doctors Guide for Long COVID

Author:: David Brzostowicki

Publish date: February 21, 2025

About 17 million Americans may have long COVID most of whom recover within 3 years.

News

New Therapy Brings Hope for Dry AMD Vision Loss

Author:: David Brzostowicki

Publish date: January 9, 2025

Photobiomodulation works by delivering specific wavelengths of light to the retina that help cells in retinal tissue, increasing energy production ...

News

How Much Does Long COVID Cost Society? New Data Shed Light

Author:: David Brzostowicki

Publish date: October 22, 2024

Long COVID is estimated to affect 6%-7% of adults; those afflicted are often unable to work for extended periods, and some simply stop working alto...

News

Paxlovid, Supplements May Improve Long COVID Symptoms

Author:: David Brzostowicki

Publish date: July 29, 2024

Long COVID, which is not yet well defined, may be helped by antivirals, Paxlovid, or supplements, studies find.

News

Scientist Aims to Unravel Long COVID’s Neurologic Impacts

Author:: David Brzostowicki

Publish date: July 17, 2024

Patients with long COVID often experience dysautonomia symptoms, including fatigue, brain fog, and dizziness.

News

New Drug Offers Hope for CPAP-Free Nights for Sleep Apnea

Author:: David Brzostowicki

Publish date: May 31, 2024

Pill aimed at treating sleep apnea in phase 3 trials and shows improvement in fatigue.

News

Getting Reluctant Patients to ‘Yes’ on COVID Vaccination

Author:: David Brzostowicki

Publish date: March 25, 2024

Be patient, acknowledge concerns, appeal to hearts not minds, and make it personal.